| GTO ID | GTC1619 |
| Trial ID | NCT02808364 |
| Disease | Glioblastoma |
| Therapy | mRNA vaccine |
| Treatment | PercellsVac3 |
| Phase | Phase1 |
| Recruitment status | Completed |
| Title | Personalized Cellular Vaccine Therapy in Treating Patients With Recurrent Glioblastoma (PerCellVac2) |
| Year | 2016 |
| Country | China |
| Company sponsor | Guangdong 999 Brain Hospital |
| Other ID(s) | Ag-mRNA-Cell-999brain |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||||
|
|||||||||||